Healthcare - Biotechnology - NASDAQ - US
$ 2.427
-4.45 %
$ 2.93 M
Market Cap
-0.5
P/E
INCOME STATEMENT
450 K
REVENUE
-4.75 M
OPERATING INCOME
-4.62 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Lipella Pharmaceuticals Inc.
| Revenue | 450 K |
| Cost Of Revenue | 3.04 M |
| Gross Profit | -2.59 M |
| Operating Expenses | 2.16 M |
| Operating Income | -4.75 M |
| Other Expenses | -127 K |
| Net Income | -4.62 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0.4 | 0.2 | 0.3 | 1.0 | 0.7 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 3.0 | 2.5 | 1.5 | 1.0 | 0.7 |
| Gross Profit | (2.6) | (2.4) | (1.2) | 14.3 K | 11.9 K |
| OPERATING INCOME | |||||
| Operating Expenses | 2.2 | 2.8 | 2.2 | 1.0 | 0.7 |
| Selling, General and Administrative Expenses | 2.2 | 0.2 | 0.7 | 42.6 K | 65.6 K |
| Research and Development Expenses | 3.0 | 2.5 | 1.5 | 1.0 | 0.7 |
| Operating Income | (4.7) | (2.6) | (1.9) | 56.9 K | 53.8 K |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 10.8 K | 9.61 K | 6.83 K | 7.96 K | 8.39 K |
| Total Other Income | 0.1 | 7.98 K | 50.4 K | 4.79 K | 8.06 K |
| Pre-Tax Income | (4.6) | (2.6) | (1.9) | 61.7 K | 61.8 K |
| NET INCOME | |||||
| Tax Provision | 0 | 1.63 K | 6.73 K | 4.79 K | 53.8 K |
| Net Income | (4.6) | (2.6) | (1.9) | 66.4 K | 61.8 K |
| EPS | 0.77 | 0.45 | 0.33 | 0.0117 | 0.0109 |